Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Clinical Trials as Topic"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 64168
Tytuł:
Exclusion of Families Who Speak Languages Other than English from Federally Funded Pediatric Trials.
Autorzy:
Anwar A; PolicyLab, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.
Dawson-Hahn E; Center for Child Health, Behavior and Development, Seattle Children's Research Institute, University of Washington School of Medicine, Seattle, WA.
Lion KC; Center for Child Health, Behavior and Development, Seattle Children's Research Institute, University of Washington School of Medicine, Seattle, WA.
Jimenez ME; Department of Pediatrics, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ.
Yun K; PolicyLab, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA. Electronic address: .
Pokaż więcej
Źródło:
The Journal of pediatrics [J Pediatr] 2023 Nov; Vol. 262, pp. 113597. Date of Electronic Publication: 2023 Jul 01.
Typ publikacji:
Review; Journal Article
MeSH Terms:
Language*
Clinical Trials as Topic*
Patient Participation*
Child ; Humans ; Ethnicity ; Hispanic or Latino ; Minority Groups ; United States ; Patient Selection
Czasopismo naukowe
Szczegóły
Tytuł:
The changing landscape of clinical trials in Australia.
Autorzy:
Seidler AL; NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW.
Willson ML; NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW.
Aberoumand M; NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW.
Williams JG; NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW.
Hunter KE; NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW.
Barba A; NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW.
Simes RJ; NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW.
Webster A; NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW.
Pokaż więcej
Źródło:
The Medical journal of Australia [Med J Aust] 2023 Sep 04; Vol. 219 (5), pp. 192-196. Date of Electronic Publication: 2023 Aug 13.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Registries*
Clinical Trials as Topic*
Humans ; Australia
Czasopismo naukowe
Szczegóły
Tytuł:
Optimal trial design selection: a comparative analysis between two-arm and three-arm trials incorporating network meta-analysis for evaluating a new treatment.
Autorzy:
Ye F; Department of Statistics, College of Liberal Arts and Sciences, Iowa State University, Ames, IA, USA.
Wang C; Department of Statistics, College of Liberal Arts and Sciences, Iowa State University, Ames, IA, USA. .; Department of Veterinary Diagnostic and Production Animal Medicine, College of Veterinary Medicine, Iowa State University, Ames, IA, USA. .
O'Connor AM; Department of Veterinary Diagnostic and Production Animal Medicine, College of Veterinary Medicine, Iowa State University, Ames, IA, USA.; Department of Large Animal Clinical Sciences, College of Veterinary Medicine, Michigan State University, East Lansing, MI, USA.
Pokaż więcej
Źródło:
BMC medical research methodology [BMC Med Res Methodol] 2023 Nov 11; Vol. 23 (1), pp. 267. Date of Electronic Publication: 2023 Nov 11.
Typ publikacji:
Meta-Analysis; Journal Article
MeSH Terms:
Clinical Trials as Topic*
Research Design*
Humans ; Computer Simulation ; Network Meta-Analysis ; Sample Size
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
OncoCTMiner: streamlining precision oncology trial matching via molecular profile analysis.
Autorzy:
Xu Q; Department of Bioinformatics, Beijing ChosenMed Clinical Laboratory Co. Ltd., Jinghai Industrial Park, 156 Jinghai 4th Road, Economic and Technological Development Area, Beijing 100176, China.; Research and Development Center, ChosenMed Technology (Zhejiang) Co. Ltd., Room 101, Building 8, Jincheng International Science and Technology City, No. 26 Zhenxing East Road, Linping District, Hangzhou, 311103, China.
Liu Y; Department of Bioinformatics, Beijing ChosenMed Clinical Laboratory Co. Ltd., Jinghai Industrial Park, 156 Jinghai 4th Road, Economic and Technological Development Area, Beijing 100176, China.
Sun D; Department of Bioinformatics, Beijing ChosenMed Clinical Laboratory Co. Ltd., Jinghai Industrial Park, 156 Jinghai 4th Road, Economic and Technological Development Area, Beijing 100176, China.; Research and Development Center, ChosenMed Technology (Zhejiang) Co. Ltd., Room 101, Building 8, Jincheng International Science and Technology City, No. 26 Zhenxing East Road, Linping District, Hangzhou, 311103, China.
Huang X; Department of Bioinformatics, Beijing ChosenMed Clinical Laboratory Co. Ltd., Jinghai Industrial Park, 156 Jinghai 4th Road, Economic and Technological Development Area, Beijing 100176, China.
Li F; Department of Bioinformatics, Beijing ChosenMed Clinical Laboratory Co. Ltd., Jinghai Industrial Park, 156 Jinghai 4th Road, Economic and Technological Development Area, Beijing 100176, China.
Zhai J; Department of Bioinformatics, Beijing ChosenMed Clinical Laboratory Co. Ltd., Jinghai Industrial Park, 156 Jinghai 4th Road, Economic and Technological Development Area, Beijing 100176, China.
Li Y; Beijing International Center for Mathematical Research, Peking University, No. 5 Yiheyuan Road Haidian District, Beijing 100871, China.; Chongqing Research Institute of Big Data, Peking University, Chongqing 401333, China.
Zhou Q; Department of Bioinformatics, Beijing ChosenMed Clinical Laboratory Co. Ltd., Jinghai Industrial Park, 156 Jinghai 4th Road, Economic and Technological Development Area, Beijing 100176, China.; Research and Development Center, ChosenMed Technology (Zhejiang) Co. Ltd., Room 101, Building 8, Jincheng International Science and Technology City, No. 26 Zhenxing East Road, Linping District, Hangzhou, 311103, China.
Qian N; Department of Oncology, Senior Department of Respiratory and Critical Care Medicine, The Eighth Medical Center of Chinese PLA General Hospital, No.17 A Heishanhu Road, Haidian District, Beijing 100853, China.
Niu B; Computer Network Information Center, Chinese Academy of Sciences, Beijing 100190, China.; University of Chinese Academy of Sciences, Beijing 100190, China.
Pokaż więcej
Źródło:
Database : the journal of biological databases and curation [Database (Oxford)] 2023 Nov 04; Vol. 2023.
Typ publikacji:
Journal Article
MeSH Terms:
Neoplasms*/therapy
Neoplasms*/drug therapy
Clinical Trials as Topic*
Humans ; Biomarkers ; Medical Oncology ; Precision Medicine
Czasopismo naukowe
Szczegóły
Tytuł:
'Being disabled' as an exclusion criterion for clinical trials: a scoping review.
Autorzy:
Camanni G; Rehabilitation Unit, Istituto Serafico, Assisi; Perugia, Italy .
Ciccone O; Rehabilitation Unit, Istituto Serafico, Assisi; Perugia, Italy.
Lepri A; Rehabilitation Unit, Istituto Serafico, Assisi; Perugia, Italy.
Tinarelli C; Rehabilitation Unit, Istituto Serafico, Assisi; Perugia, Italy.
Bedetti C; Department of Neurology, Città di Castello Hospital, Citta di Castello, Italy.
Cicuttin S; Rehabilitation Unit, Istituto Serafico, Assisi; Perugia, Italy.
Murgia N; Department of Environmental Science and Prevention, University of Ferrara, Ferrara, Italy.
Elisei S; Rehabilitation Unit, Istituto Serafico, Assisi; Perugia, Italy.
Pokaż więcej
Źródło:
BMJ global health [BMJ Glob Health] 2023 Nov; Vol. 8 (11).
Typ publikacji:
Journal Article; Systematic Review
MeSH Terms:
Disabled Persons*
Patient Selection*
Clinical Trials as Topic*
Humans
Czasopismo naukowe
Szczegóły
Tytuł:
Cancer trial results show power of weaponized antibodies.
Autorzy:
Ledford H
Pokaż więcej
Źródło:
Nature [Nature] 2023 Nov; Vol. 623 (7986), pp. 231-232.
Typ publikacji:
Wiadomości
MeSH Terms:
Antibodies, Neoplasm*/immunology
Antibodies, Neoplasm*/therapeutic use
Clinical Trials as Topic*
Urinary Bladder Neoplasms*/drug therapy
Urinary Bladder Neoplasms*/immunology
Humans ; Immunoconjugates/chemistry ; Immunoconjugates/immunology ; Immunoconjugates/therapeutic use ; Treatment Outcome
Periodyk
Szczegóły
Tytuł:
Identifying the patient harms to include in an in silico clinical trial.
Autorzy:
Favre P; Zimmer Biomet, Zählerweg 4, Zug 6300, Switzerland. Electronic address: .
Bischoff J; Zimmer Biomet, 1800 West Center Street, Warsaw, IN 46580, USA.
Pokaż więcej
Źródło:
Computer methods and programs in biomedicine [Comput Methods Programs Biomed] 2023 Nov; Vol. 241, pp. 107735. Date of Electronic Publication: 2023 Jul 30.
Typ publikacji:
Journal Article
MeSH Terms:
Clinical Trials as Topic*
Patient Harm*
Humans ; Computer Simulation
Czasopismo naukowe
Szczegóły
Tytuł:
Do Current Lung Cancer Clinical Trials Represent All Patient Populations Including Minorities?
Autorzy:
Nemala A; Medical College of Georgia, Augusta, GA.
Ullah A; Department of Pathology, Texas Tech University Health Sciences Center, Lubbock, TX.
Yacur M; Department of Hematology-Oncology, Inova Schar Cancer Institute, University of Virginia, Fairfax, VA.
Karim NA; Department of Hematology-Oncology, Inova Schar Cancer Institute, University of Virginia, Fairfax, VA. Electronic address: .
Pokaż więcej
Źródło:
Clinical lung cancer [Clin Lung Cancer] 2023 Nov; Vol. 24 (7), pp. 573-580. Date of Electronic Publication: 2023 Aug 05.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Lung Neoplasms*/therapy
Minority Groups*
Clinical Trials as Topic*
Humans ; Patient Selection ; Racial Groups ; United States
Czasopismo naukowe
Szczegóły
Tytuł:
A 10-year update to the principles for clinical trial data sharing by pharmaceutical companies: perspectives based on a decade of literature and policies.
Autorzy:
Modi ND; College of Medicine and Public Health, Flinders University, Adelaide, SA, Australia.
Kichenadasse G; College of Medicine and Public Health, Flinders University, Adelaide, SA, Australia.; Flinders Centre for Innovation in Cancer, Department of Medical Oncology, Flinders Medical Centre, Adelaide, SA, Australia.
Hoffmann TC; Institute for Evidence-Based Healthcare, Faculty of Health Sciences and Medicine, Bond University, Gold Coast, QLD, Australia.
Haseloff M; Adelaide, Australia.
Logan JM; Clinical and Health Sciences, University of South Australia, Adelaide, SA, Australia.
Veroniki AA; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada.; Knowledge Translation Program, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Canada.
Venchiarutti RL; Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW, Australia.; Department of Head and Neck Surgery, Chris O'Brien Lifehouse, Sydney, NSW, Australia.
Smit AK; The Daffodil Centre, The University of Sydney, A Joint Venture with Cancer Council NSW, Sydney, NSW, Australia.
Tuffaha H; Centre for the Business and Economics of Health, The University of Queensland, Brisbane, QLD, Australia.
Jayasekara H; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, VIC, Australia.; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia.; School of Public Health and Preventive Medicine, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, VIC, Australia.
Manning-Bennet A; College of Medicine and Public Health, Flinders University, Adelaide, SA, Australia.
Morton E; College of Medicine and Public Health, Flinders University, Adelaide, SA, Australia.
McKinnon RA; College of Medicine and Public Health, Flinders University, Adelaide, SA, Australia.
Rowland A; College of Medicine and Public Health, Flinders University, Adelaide, SA, Australia.
Sorich MJ; College of Medicine and Public Health, Flinders University, Adelaide, SA, Australia.
Hopkins AM; College of Medicine and Public Health, Flinders University, Adelaide, SA, Australia. .
Pokaż więcej
Źródło:
BMC medicine [BMC Med] 2023 Oct 23; Vol. 21 (1), pp. 400. Date of Electronic Publication: 2023 Oct 23.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Information Dissemination*
Clinical Trials as Topic*
Humans ; Policy ; Drug Industry
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Optimizing Informed Consent in Cancer Clinical Trials.
Autorzy:
Perni S; Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Jimenez R; Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA.
Jagsi R; Department of Radiation Oncology, Winship Cancer Institute of Emory University, Atlanta, GA. Electronic address: .
Pokaż więcej
Źródło:
Seminars in radiation oncology [Semin Radiat Oncol] 2023 Oct; Vol. 33 (4), pp. 349-357.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Clinical Trials as Topic*
Informed Consent*
Neoplasms*/genetics
Neoplasms*/therapy
Humans ; Artificial Intelligence
Czasopismo naukowe
Szczegóły
Tytuł:
Neighborhood socioeconomic disadvantage measures in rehabilitation clinical trials: Lessons learned in recruitment.
Autorzy:
Rodriquez J; Emory University, 1441 Clifton Rd. NE, Room 213, Atlanta, GA 30322, United States of America. Electronic address: .
Bullock D; Emory University, 1441 Clifton Rd. NE, Room 213, Atlanta, GA 30322, United States of America. Electronic address: .
Cotsonis G; Department of Biostatistics and Bioinformatics, Emory University Rollins School of Public Health, 1518 Clifton Road NE, Atlanta, GA 30322, United States of America. Electronic address: .
Clark PC; Byrdine F. Lewis School of Nursing, Georgia State University, Atlanta, GA, United States of America. Electronic address: .
Blanton S; Division of Physical Therapy, Department of Rehabilitation Medicine, Emory University School of Medicine, 1441 Clifton Rd. NE, Room 213, Atlanta, GA 30322, United States of America. Electronic address: .
Pokaż więcej
Źródło:
Applied nursing research : ANR [Appl Nurs Res] 2023 Oct; Vol. 73, pp. 151718. Date of Electronic Publication: 2023 Jul 30.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Socioeconomic Disparities in Health*
Stroke*/ethnology
Stroke*/therapy
Patient Selection*
Neighborhood Characteristics*
Clinical Trials as Topic*/statistics & numerical data
Stroke Rehabilitation*/economics
Stroke Rehabilitation*/statistics & numerical data
Adult ; Aged ; Female ; Humans ; Male ; Middle Aged ; Asian ; Hospitalization ; Caregivers ; Urban Population ; Pilot Projects ; White ; Black or African American
Czasopismo naukowe
Szczegóły
Tytuł:
Characteristics of chief investigators and principal investigators in Australian and New Zealand radiation oncology clinical trials.
Autorzy:
Nguyen H; School of Medicine, The University of Notre Dame, Fremantle, Western Australia, Australia.; Genesiscare, Perth, Western Australia, Australia.; Trans Tasman Radiation Oncology Group, New South Wales, Australia.
Montgomery R; Trans Tasman Radiation Oncology Group, New South Wales, Australia.
Sundaresan P; Trans Tasman Radiation Oncology Group, New South Wales, Australia.; Sydney West Radiation Oncology Network, WSLHD, Sydney, New South Wales, Australia.; Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia.
Pokaż więcej
Źródło:
Journal of medical imaging and radiation oncology [J Med Imaging Radiat Oncol] 2023 Oct; Vol. 67 (7), pp. 703-709. Date of Electronic Publication: 2023 Jul 16.
Typ publikacji:
Journal Article
MeSH Terms:
Clinical Trials as Topic*
Radiation Oncology*
Female ; Humans ; Male ; Australia ; Neoplasms/radiotherapy ; New Zealand ; Retrospective Studies
Czasopismo naukowe
Szczegóły
Tytuł:
Clinical trials: A plea to cooperative groups, consortia, pharmaceutical companies, and lead investigators for reasonable imaging protocols.
Autorzy:
Trout AT; Department of Radiology, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Norris RE; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.; Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
de Blank PMK; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.; Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Backus LR; Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Towbin AJ; Department of Radiology, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Nash JM; Department of Radiology, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Pokaż więcej
Źródło:
Pediatric blood & cancer [Pediatr Blood Cancer] 2023 Oct; Vol. 70 (10), pp. e30362. Date of Electronic Publication: 2023 Apr 14.
Typ publikacji:
Editorial
MeSH Terms:
Clinical Trials as Topic*
Humans ; Drug Industry
Opinia redakcyjna
Szczegóły
Tytuł:
Advances and Challenges in Trials of Local Therapy for Patients With Oligometastatic or Oligoprogressive Disease.
Autorzy:
Yan M; Palliative Radiotherapy and Oligometastasis Program, Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
Abdel-Rahman F; Palliative Radiotherapy and Oligometastasis Program, Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Department of Radiation Oncology, King Hussein Cancer Center, Amman, Jordan.
Dawson L; Palliative Radiotherapy and Oligometastasis Program, Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
Wong P; Palliative Radiotherapy and Oligometastasis Program, Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
Wong RKS; Palliative Radiotherapy and Oligometastasis Program, Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
Tsai CJ; Palliative Radiotherapy and Oligometastasis Program, Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.. Electronic address: .
Pokaż więcej
Źródło:
Seminars in radiation oncology [Semin Radiat Oncol] 2023 Oct; Vol. 33 (4), pp. 416-428.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Clinical Trials as Topic*
Radiosurgery*
Humans ; Patient Selection
Czasopismo naukowe
Szczegóły
Tytuł:
Real-World Data: Applications and Relevance to Cancer Clinical Trials.
Autorzy:
Gross AJ; University Hospitals Seidman Cancer Center and Case Western Reserve University, Cleveland, OH.
Pisano CE; University Hospitals Seidman Cancer Center and Case Western Reserve University, Cleveland, OH.
Khunsriraksakul C; Penn State College of Medicine, Hershey, PA.
Spratt DE; University Hospitals Seidman Cancer Center and Case Western Reserve University, Cleveland, OH.
Park HS; Department of Therapeutic Radiology, Yale School of Medicine, New Haven, CT.
Sun Y; Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, OH.
Wang M; Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, OH.
Zaorsky NG; University Hospitals Seidman Cancer Center and Case Western Reserve University, Cleveland, OH. Electronic address: .
Pokaż więcej
Źródło:
Seminars in radiation oncology [Semin Radiat Oncol] 2023 Oct; Vol. 33 (4), pp. 374-385.
Typ publikacji:
Journal Article; Review; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Neoplasms*/epidemiology
Neoplasms*/therapy
Clinical Trials as Topic*
Humans ; Comparative Effectiveness Research ; Databases, Factual ; Medical Oncology ; Research Design
Czasopismo naukowe
Szczegóły
Tytuł:
The Importance of Quality Assurance in Radiation Oncology Clinical Trials.
Autorzy:
FitzGerald TJ; Department of Radiation Oncology, UMass Chan Medical School, Worcester, MA.. Electronic address: .
Bishop-Jodoin M; Department of Radiation Oncology, UMass Chan Medical School, Worcester, MA.
Laurie F; Department of Radiation Oncology, UMass Chan Medical School, Worcester, MA.
Iandoli M; Department of Radiation Oncology, UMass Chan Medical School, Worcester, MA.
Smith K; Department of Radiation Oncology, UMass Chan Medical School, Worcester, MA.
Ulin K; Department of Radiation Oncology, UMass Chan Medical School, Worcester, MA.
Ding L; Department of Radiation Oncology, UMass Chan Medical School, Worcester, MA.
Moni J; Department of Radiation Oncology, UMass Chan Medical School, Worcester, MA.
Cicchetti MG; Department of Radiation Oncology, UMass Chan Medical School, Worcester, MA.
Knopp M; Department of Radiology, University of Cincinnati, Cincinnati, OH.
Kry S; Department of Radiation Physics, MD Anderson Cancer Center, Houston, TX.
Xiao Y; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA.
Rosen M; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA.
Prior F; Department of Biomedical Informatics, University of Arkansas for Medical Sciences, Little Rock, AR.
Saltz J; Department of Biomedical Informatics, Stony Brook University, Stony Brook, NY.
Michalski J; Department of Radiation Oncology, Washington University in St Louis, St Louis, MO.
Pokaż więcej
Źródło:
Seminars in radiation oncology [Semin Radiat Oncol] 2023 Oct; Vol. 33 (4), pp. 395-406.
Typ publikacji:
Journal Article; Review; Research Support, N.I.H., Extramural
MeSH Terms:
Radiation Oncology*
Clinical Trials as Topic*
Humans ; Data Management ; Medical Oncology ; Records
Czasopismo naukowe
Szczegóły
Tytuł:
Review article: Externally derived control arms-An opportunity for clinical trials in inflammatory bowel disease?
Autorzy:
Honap S; Department of Gastroenterology, St George's University Hospitals NHS Foundation Trust, London, UK.; School of Immunology and Microbial Sciences, King's College London, London, UK.
Peyrin-Biroulet L; Department of Gastroenterology, INFINY Institute, FHU-CURE, Nancy University Hospital, Vandœuvre-lès-Nancy, France.; Paris IBD Center, Groupe Hospitalier Privé Ambroise Paré - Hartmann, Neuilly sur Seine, France.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Oct; Vol. 58 (7), pp. 659-667. Date of Electronic Publication: 2023 Aug 21.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Clinical Trials as Topic*
Inflammatory Bowel Diseases*/drug therapy
Humans ; Drug Development
Czasopismo naukowe
Szczegóły
Tytuł:
Integrating Artificial Intelligence and Machine Learning Into Cancer Clinical Trials.
Autorzy:
Kang J; Department of Radiation Oncology, University of Washington, Seattle, WA.. Electronic address: .
Chowdhry AK; Department of Radiation Oncology, University of Rochester, Rochester, NY.
Pugh SL; American College of Radiology, NRG Oncology Statistics and Data Management Center, Philadelphia PA.
Park JH; Department of Radiation Oncology, Kansas City VA Medical Center, Kansas City, MO.; Department of Radiology, University of Missouri Kansas City School of Medicine, Kansas City, MO.
Pokaż więcej
Źródło:
Seminars in radiation oncology [Semin Radiat Oncol] 2023 Oct; Vol. 33 (4), pp. 386-394.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Artificial Intelligence*
Neoplasms*/therapy
Clinical Trials as Topic*
Humans ; Machine Learning ; Medical Oncology ; Prospective Studies
Czasopismo naukowe
Szczegóły
Tytuł:
Differential patient travel distance and time to psoriasis clinical trial sites.
Autorzy:
Masison J; University of Connecticut School of Medicine, Farmington, CT, USA.
Beltrami EJ; University of Connecticut School of Medicine, Farmington, CT, USA.
Feng H; Department of Dermatology, University of Connecticut Health Center, 21 South Rd, 2nd Floor, Farmington, CT, 06032, USA. .
Pokaż więcej
Źródło:
Archives of dermatological research [Arch Dermatol Res] 2023 Oct; Vol. 315 (8), pp. 2359-2363. Date of Electronic Publication: 2023 May 11.
Typ publikacji:
Journal Article
MeSH Terms:
Health Services Accessibility*/statistics & numerical data
Travel*/statistics & numerical data
Clinical Trials as Topic*/statistics & numerical data
Psoriasis*/epidemiology
Psoriasis*/ethnology
Psoriasis*/therapy
Healthcare Disparities*/ethnology
Healthcare Disparities*/statistics & numerical data
Humans ; Black People/statistics & numerical data ; Rural Population/statistics & numerical data ; United States/epidemiology ; American Indian or Alaska Native/statistics & numerical data
Czasopismo naukowe
Szczegóły
Tytuł:
Why do authors persist in submitting trial reports that do not meet the journal eligibility criteria or AllTrials standards?
Autorzy:
Noyes J; School of Medical and Health Sciences, Bangor University, Bangor, UK.; Editor Journals of Advanced Nursing, Clinical Nursing and Nursing Open, Wiley, Oxford, UK.
Pokaż więcej
Źródło:
Journal of advanced nursing [J Adv Nurs] 2023 Oct; Vol. 79 (10), pp. 3646-3647. Date of Electronic Publication: 2023 Mar 13.
Typ publikacji:
Editorial
MeSH Terms:
Publishing*
Clinical Trials as Topic*
Humans ; Reference Standards
Opinia redakcyjna
Szczegóły
Wyświetlanie 1-20 z 64168

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies